文献速递前列腺癌

报告前列腺癌家族史的不同队列先证者中疑似遗传性癌症综合征及胚系突变的患病率:迈向为男性提供级联检测信息

Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.
PubMed 文献 · Eur Urol Oncol · 2019-07-03

该前瞻性遗传检测数据库研究分析了345例报告前列腺癌家族史的先证者,其中53例非裔美国人、292例白人。63.8%的先证者符合至少一种与前列腺癌家族史潜在相关的遗传性癌症综合征标准(非裔美国人75.5%,白人61.6%)。在169例接受基因检测的先证者中,19.5%检出胚系突变。

要点

  • 345例报告前列腺癌家族史的先证者中,63.8%符合至少一种遗传性癌症综合征标准。
  • 非裔美国人先证者符合遗传性乳腺癌和卵巢癌综合征的比例高于白人(90.2% vs 74.6%,p=0.04)。
  • 接受基因检测的169例先证者中,19.5%检出胚系突变,非裔美国人突变均位于BRCA1/2。

核心结论

  • 相当比例的报告前列腺癌家族史的非裔美国人先证者符合遗传性癌症综合征标准,其中遗传性乳腺癌和卵巢癌综合征检出率最高。
  • 尽管样本量有限,研究结果提示与非裔美国人家庭中前列腺癌家族史相关的遗传性癌症综合征涉及BRCA突变,强调需要更多非裔美国人参与者加入遗传学研究。

研究设计与样本

  • 前瞻性遗传检测数据库查询有前列腺癌家族史的个体。
  • 对系谱进行分析以评估三种遗传性癌症综合征:遗传性乳腺癌和卵巢癌综合征、遗传性前列腺癌和Lynch综合征。
  • 共纳入345例报告前列腺癌家族史的先证者,其中53例非裔美国人,292例白人。

主要发现

  • 总体220例先证者(63.8%)符合至少一种与前列腺癌家族史潜在相关的遗传性癌症综合征标准(非裔美国人75.5%;白人61.6%)。
  • 与非裔美国人先证者相比,白人中与前列腺癌家族史相关的遗传性乳腺癌和卵巢癌综合征比例较低(90.2% vs 74.6%,p=0.04)。
  • 在169例接受基因检测且符合任何与前列腺癌家族史潜在相关的遗传性癌症综合征的先证者中,19.5%检出胚系突变。
  • 5例非裔美国人先证者检出胚系突变(均位于BRCA1/2),28例白人先证者检出突变,涉及多个基因。

局限性

  • 尽管样本量有限,研究结果提示与非裔美国人家庭中前列腺癌家族史相关的遗传性癌症综合征涉及BRCA突变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prostate cancer (PCa) is increasingly recognized as part of hereditary cancer syndromes (HCSs). HCS prevalence among diverse probands seeking genetic evaluation with PCa family history (FHx) has not been reported and has implications for cascade genetic testing. OBJECTIVE: To evaluate the rates of HCSs among probands reporting PCa FHx and germline mutations among probands. DESIGN, SETTING, AND PARTICIPANTS: A prospective genetic testing database queried for individuals with PCa FHx. Pedigrees analyzed for three HCSs: hereditary breast and ovarian cancer (HBOC), hereditary PCa, and Lynch syndrome. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Associations between HCS overall, and with plausible link to PCA FHx and race evaluated using Fisher's exact test. Germline mutation rates described among probands with a suspicion of an HCS connected with PCa FHx. RESULTS AND LIMITATIONS: A total of 345 probands reported PCa FHx: 53 African American (AA) and 292 Caucasian (Wh). Overall, 220 probands (63.8%) met the criteria for at least one HCS with a potential link to PCa FHx (75.5% AA; 61.6% Wh). HBOC linked to PCa FHx was identified in a higher percentage of AA than Wh probands (90.2% vs 74.6%, p=0.04). Among probands who underwent genetic testing with any HCS potentially linked to PCa FHx (n=169), 19.5% had germline mutations identified; five AA probands had germline mutations (all in BRCA1/2), while 28 Wh probands had mutations in a spectrum of genes. CONCLUSIONS: A significant percentage of AA probands with PCa FHx meet the criteria for HCSs, with HBOC identified at the highest rate. Although limited in sample size, our findings implicate BRCA mutations in AA families with HCSs linked with PCa, underscoring the need for greater enrollment of AA participants in genetic studies. PATIENT SUMMARY: Hereditary cancer syndromes potentially linked to prostate cancer are common in patients reporting a family history of prostate cancer. African-American patients may need special attention with regard to testing for hereditary breast and ovarian cancer syndrome, which may impact men with prostate cancer in these families.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Chandrasekar T, Gross L, Gomella LG, et al. Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men. Eur Urol Oncol. 2019. PMID: 31278035. doi:10.1016/j.euo.2019.06.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。